These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 24251585

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Comments on 'A quantitative model of amphetamine action on the serotonin transporter', by Sandtner et al., Br J Pharmacol 171: 1007-1018.
    De Felice LJ, Cameron KN.
    Br J Pharmacol; 2015 Oct; 172(19):4772-4. PubMed ID: 24824549
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The conservative view: is it necessary to implant a stent into the dopamine transporter?
    Schmid D, Koenig X, Bulusu S, Schicker K, Freissmuth M, Sitte HH, Sandtner W.
    Br J Pharmacol; 2015 Oct; 172(19):4775-8. PubMed ID: 24824446
    [Abstract] [Full Text] [Related]

  • 5. Acceleration of serotonin transporter transport-associated current by 3,4-methylenedioxymethamphetamine (MDMA) under acidic conditions.
    Yamauchi Y, Izumi T, Unemura K, Uenishi Y, Nakagawa T, Kaneko S.
    Neurosci Lett; 2007 Nov 27; 428(2-3):72-6. PubMed ID: 17949903
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. MDMA (Ecstasy) and human dopamine, norepinephrine, and serotonin transporters: implications for MDMA-induced neurotoxicity and treatment.
    Verrico CD, Miller GM, Madras BK.
    Psychopharmacology (Berl); 2007 Jan 27; 189(4):489-503. PubMed ID: 16220332
    [Abstract] [Full Text] [Related]

  • 8. Characterization of the translocation of protein kinase C (PKC) by 3,4-methylenedioxymethamphetamine (MDMA/ecstasy) in synaptosomes: evidence for a presynaptic localization involving the serotonin transporter (SERT).
    Kramer HK, Poblete JC, Azmitia EC.
    Neuropsychopharmacology; 1998 Oct 27; 19(4):265-77. PubMed ID: 9718590
    [Abstract] [Full Text] [Related]

  • 9. N,N-dimethyl-thioamphetamine and methyl-thioamphetamine, two non-neurotoxic substrates of 5-HT transporters, have scant in vitro efficacy for the induction of transporter-mediated 5-HT release and currents.
    Gobbi M, Funicello M, Gerstbrein K, Holy M, Moya PR, Sotomayor R, Forray MI, Gysling K, Paluzzi S, Bonanno G, Reyes-Parada M, Sitte HH, Mennini T.
    J Neurochem; 2008 Jun 27; 105(5):1770-80. PubMed ID: 18248615
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Carrier-dependent and Ca(2+)-dependent 5-HT and dopamine release induced by (+)-amphetamine, 3,4-methylendioxymethamphetamine, p-chloroamphetamine and (+)-fenfluramine.
    Crespi D, Mennini T, Gobbi M.
    Br J Pharmacol; 1997 Aug 27; 121(8):1735-43. PubMed ID: 9283711
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. p-Methylthioamphetamine and 1-(m-chlorophenyl)piperazine, two non-neurotoxic 5-HT releasers in vivo, differ from neurotoxic amphetamine derivatives in their mode of action at 5-HT nerve endings in vitro.
    Gobbi M, Moia M, Pirona L, Ceglia I, Reyes-Parada M, Scorza C, Mennini T.
    J Neurochem; 2002 Sep 27; 82(6):1435-43. PubMed ID: 12354291
    [Abstract] [Full Text] [Related]

  • 15. The profile of mephedrone on human monoamine transporters differs from 3,4-methylenedioxymethamphetamine primarily by lower potency at the vesicular monoamine transporter.
    Pifl C, Reither H, Hornykiewicz O.
    Eur J Pharmacol; 2015 May 15; 755():119-26. PubMed ID: 25771452
    [Abstract] [Full Text] [Related]

  • 16. Loss of serotonin transporter protein after MDMA and other ring-substituted amphetamines.
    Xie T, Tong L, McLane MW, Hatzidimitriou G, Yuan J, McCann U, Ricaurte G.
    Neuropsychopharmacology; 2006 Dec 15; 31(12):2639-51. PubMed ID: 16452989
    [Abstract] [Full Text] [Related]

  • 17. A kinetic account for amphetamine-induced monoamine release.
    Hasenhuetl PS, Bhat S, Mayer FP, Sitte HH, Freissmuth M, Sandtner W.
    J Gen Physiol; 2018 Mar 05; 150(3):431-451. PubMed ID: 29439119
    [Abstract] [Full Text] [Related]

  • 18. Identifying the serotonin transporter signal in Western blot studies of the neurotoxic potential of MDMA and related drugs.
    McLane MW, McCann U, Ricaurte G.
    Synapse; 2011 Dec 05; 65(12):1368-72. PubMed ID: 21633976
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A genetic deletion of the serotonin transporter differentially influences the behavioural effects of MDMA.
    Pettie M, Oakly A, Harper DN, Ellenbroek BA.
    J Psychopharmacol; 2019 Mar 05; 33(3):355-363. PubMed ID: 30665313
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.